The discriminatory diagnostic value of multimodal ultrasound combined with blood cell analysis for granulomatous lobular mastitis and invasive ductal carcinoma of the breast

被引:1
|
作者
Zeng, Yan-hao [1 ]
Yang, Yu-ping [1 ]
Liu, Li-juan [1 ]
Xie, Jun [1 ]
Dai, Hai-xia [1 ]
Zhou, Hong-lian [1 ]
Huang, Xing [1 ]
Huang, Rong-li [1 ]
Liu, Er-qiu [1 ]
Deng, Yi-jing [1 ]
Li, Hua-juan [1 ]
Wu, Jia-jian [1 ]
Zhang, Guo-li [1 ]
Liao, Man-li [1 ]
Xu, Xiao-hong [1 ]
机构
[1] Guangdong Med Univ, Dept Ultrasound, Affiliated Hosp, 57 Southern Renmin Ave, Zhanjiang 524000, Peoples R China
关键词
Ultrasound; blood cell analysis; granulomatous lobular mastitis; invasive ductal carcinoma; CONTRAST-ENHANCED ULTRASONOGRAPHY; COLOR DOPPLER US; CANCER; ELASTOGRAPHY; BENIGN;
D O I
10.3233/CH-231999
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To explore the discriminatory diagnostic value of multimodal ultrasound (US) combined with blood cell analysis (BCA) for Granulomatous Lobular Mastitis (GLM) and Invasive Ductal Carcinoma (IDC) of the breast. METHODS: A total of 157 breast disease patients were collected and divided into two groups based on postoperative pathological results: the GLM group (57 cases with 57 lesions) and the IDC group (100 cases with 100 lesions). Differences in multimodal ultrasound features and the presence of BCA were compared between the two groups. The receiver operating characteristic (ROC) curve was used to calculate the optimal cutoff values, sensitivity, specificity, 95% confidence interval (CI), and the area under the curve (AUC) for patient age, lesion size, lesion resistive index (RI), and white blood cell (WBC) count in BCA. Sensitivity, specificity, positive predictive value, negative predictive value, diagnostic accuracy, and AUC were calculated for different diagnostic methods. RESULTS: There were statistically significant differences (P < 0.05) observed betweenGLMandIDCpatients in terms of age, breast pain, the factors in Conventional US (lesion size, RI, nipple delineation, solitary/multiple lesions, margin, liquefaction area, growth direction, microcalcifications, posterior echogenicity and abnormal axillary lymph nodes), the factors in CEUS (contrast agent enhancement intensity, enhancement pattern, enhancement range, and crab-like enhancement) and the factors in BCA (white blood cells, neutrophils, lymphocytes and monocytes). ROC curve analysis results showed that the optimal cutoff values for distinguishing GLM from IDC were 40.5 years for age, 7.15 cm for lesion size, 0.655 for lesion RI, and 10.525*109/L for white blood cells. The diagnostic accuracy of conventional US combined with CEUS (US-CEUS) was the highest (97.45%). The diagnostic performanceAUCs for US-CEUS, CEUS, andUSwere 0.965, 0.921 and 0.832, respectively. CONCLUSION: Multifactorial analysis of multimodal ultrasound features and BCA had high clinical application value in the differential diagnosis of GLM and IDC.
引用
收藏
页码:481 / 493
页数:13
相关论文
共 50 条
  • [21] Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma
    James W Horvath
    Gary E Barnett
    Rafael E Jimenez
    Donn C Young
    Stephen P Povoski
    World Journal of Surgical Oncology, 7
  • [22] Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma
    Horvath, James W.
    Barnett, Gary E.
    Jimenez, Rafael E.
    Young, Donn C.
    Povoski, Stephen P.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7
  • [23] Evaluating Surgical Outcomes Between Estrogen Receptor Positive Invasive Lobular and Invasive Ductal Carcinoma of the Breast-A Propensity Matched Analysis
    O'Connor, Domhnall J.
    Davey, Matthew G.
    Mcfeetors, Carson
    Mclaughlin, Ray P.
    Sweeney, Karl J.
    Barry, Michael K.
    Malone, Carmel M.
    Abd El Wahab, Sami
    Lowery, Aoife J.
    Kerin, Michael J.
    CLINICAL BREAST CANCER, 2024, 24 (08) : e655 - e662
  • [24] Diagnostic value and clinical significance of ultrasound combined with CT in cystic renal cell carcinoma
    Sun, Minghui
    Wang, Chao
    Jiang, Fei
    Fang, Xiuhong
    Guo, Bingcheng
    ONCOLOGY LETTERS, 2019, 18 (02) : 1395 - 1401
  • [25] Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma in situ
    Zhao, Suhong
    Shao, Guangrui
    Chen, Peipei
    Li, Liang
    Yang, Yuhai
    Zhao, Xianhua
    Guo, Weihua
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (04) : 871 - 875
  • [26] White blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma
    Mantas, Dimitrios
    Kostakis, Ioannis D.
    Machairas, Nikolaos
    Markopoulos, Christos
    ONCOLOGY LETTERS, 2016, 12 (02) : 1610 - 1614
  • [27] Image Features and Diagnostic Value of Contrast-Enhanced Ultrasound for Ductal Carcinoma In Situ of the Breast: Preliminary Findings
    Li, Weiwei
    Zhao, Yingyan
    Fei, Xiaochun
    Wu, Ying
    Zhan, Weiwei
    Zhou, Wei
    Xia, Shujun
    Song, Yanyan
    Zhou, Jianqiao
    ULTRASONIC IMAGING, 2025, 47 (02) : 59 - 67
  • [28] Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas
    Frolik, D
    Caduff, R
    Varga, Z
    HISTOPATHOLOGY, 2001, 39 (05) : 503 - 513
  • [29] Does the number of cell forming tumor budding alter the prognostic value in invasive ductal carcinoma of breast?
    Ozturk, Cigdem
    Askan, Gokce
    Ozturk, Seda Duman
    Okcu, Oguzhan
    Sen, Bayram
    Bedir, Recep
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
  • [30] Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis
    Wang, Liye
    Sun, Peng
    Xu, Fei
    Zheng, Qiufan
    Jiang, Kuikui
    Hong, Ruoxi
    Wang, Shusen
    CANCER MEDICINE, 2024, 13 (01):